Zhejiang Jiuzhou Pharmaceutical Co Ltd
SSE:603456
Zhejiang Jiuzhou Pharmaceutical Co Ltd
Operating Income
Zhejiang Jiuzhou Pharmaceutical Co Ltd
Operating Income Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Operating Income | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
Z
|
Zhejiang Jiuzhou Pharmaceutical Co Ltd
SSE:603456
|
Operating Income
¥733.3m
|
CAGR 3-Years
-1%
|
CAGR 5-Years
19%
|
CAGR 10-Years
17%
|
|
|
H
|
Hansoh Pharmaceutical Group Company Ltd
HKEX:3692
|
Operating Income
¥5.1B
|
CAGR 3-Years
20%
|
CAGR 5-Years
13%
|
CAGR 10-Years
N/A
|
|
|
Zhangzhou Pientzehuang Pharmaceutical Co Ltd
SSE:600436
|
Operating Income
¥3.5B
|
CAGR 3-Years
10%
|
CAGR 5-Years
20%
|
CAGR 10-Years
24%
|
|
|
Jiangsu Hengrui Pharmaceuticals Co Ltd
SSE:600276
|
Operating Income
¥6.8B
|
CAGR 3-Years
19%
|
CAGR 5-Years
4%
|
CAGR 10-Years
15%
|
|
|
C
|
CSPC Innovation Pharmaceutical Co Ltd
SZSE:300765
|
Operating Income
-¥261.3m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
S
|
Sichuan Biokin Pharmaceutical Co Ltd
SSE:688506
|
Operating Income
¥3.7B
|
CAGR 3-Years
N/A
|
CAGR 5-Years
203%
|
CAGR 10-Years
N/A
|
|
Zhejiang Jiuzhou Pharmaceutical Co Ltd
Glance View
Founded in 1973, Zhejiang Jiuzhou Pharmaceutical Co. Ltd. has steadily navigated the evolving tides of the global pharmaceutical industry with a compelling blend of innovation and traditional business acumen. Rooted in China's dynamic Zhejiang province, the company initially focused on manufacturing basic pharmaceutical intermediates. Over the years, it strategically expanded its operations, becoming a key player in both the Active Pharmaceutical Ingredients (APIs) and Contract Development and Manufacturing Organization (CDMO) sectors. This dual focus has allowed Jiuzhou Pharmaceutical to innovate and offer comprehensive services, ranging from drug development to commercial manufacturing, effectively appealing to a broad range of customers including some of the world's leading pharmaceutical companies. At the heart of Jiuzhou Pharmaceutical's success lies its commitment to research and development, a cornerstone that supports its diversification strategy. The company leverages its extensive expertise and cutting-edge technology to improve existing drugs while also participating in the development of new, patented pharmaceuticals. By fostering strong partnerships with global pharmaceutical giants, Jiuzhou effectively integrates itself into the larger pharmaceutical ecosystem, providing customized solutions that resonate with market demand. This business model not only reinforces its financial growth but also establishes Zhejiang Jiuzhou as an indispensable contributor to advancements in medicine, continually enhancing its reputation on the international stage.
See Also
What is Zhejiang Jiuzhou Pharmaceutical Co Ltd's Operating Income?
Operating Income
733.3m
CNY
Based on the financial report for Dec 31, 2024, Zhejiang Jiuzhou Pharmaceutical Co Ltd's Operating Income amounts to 733.3m CNY.
What is Zhejiang Jiuzhou Pharmaceutical Co Ltd's Operating Income growth rate?
Operating Income CAGR 10Y
17%
Over the last year, the Operating Income growth was -35%. The average annual Operating Income growth rates for Zhejiang Jiuzhou Pharmaceutical Co Ltd have been -1% over the past three years , 19% over the past five years , and 17% over the past ten years .
You don't have any saved screeners yet